nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—Arrhythmia—Rosuvastatin—atherosclerosis	0.0167	0.0296	CcSEcCtD
Mivacurium—Flushing—Lovastatin—atherosclerosis	0.0147	0.026	CcSEcCtD
Mivacurium—Flushing—Ezetimibe—atherosclerosis	0.0145	0.0255	CcSEcCtD
Mivacurium—Angiopathy—Ezetimibe—atherosclerosis	0.0141	0.025	CcSEcCtD
Mivacurium—Immune system disorder—Ezetimibe—atherosclerosis	0.0141	0.0249	CcSEcCtD
Mivacurium—Mediastinal disorder—Ezetimibe—atherosclerosis	0.014	0.0248	CcSEcCtD
Mivacurium—Flushing—Simvastatin—atherosclerosis	0.0138	0.0244	CcSEcCtD
Mivacurium—Erythema—Ezetimibe—atherosclerosis	0.0136	0.024	CcSEcCtD
Mivacurium—Muscle spasms—Lovastatin—atherosclerosis	0.0133	0.0235	CcSEcCtD
Mivacurium—Muscle spasms—Ezetimibe—atherosclerosis	0.013	0.023	CcSEcCtD
Mivacurium—Erythema—Simvastatin—atherosclerosis	0.0129	0.0228	CcSEcCtD
Mivacurium—Flushing—Niacin—atherosclerosis	0.0127	0.0224	CcSEcCtD
Mivacurium—Flushing—Pravastatin—atherosclerosis	0.0125	0.022	CcSEcCtD
Mivacurium—Cardiac disorder—Pravastatin—atherosclerosis	0.0125	0.022	CcSEcCtD
Mivacurium—Muscle spasms—Simvastatin—atherosclerosis	0.0124	0.022	CcSEcCtD
Mivacurium—Angiopathy—Niacin—atherosclerosis	0.0124	0.0219	CcSEcCtD
Mivacurium—Arrhythmia—Niacin—atherosclerosis	0.0122	0.0215	CcSEcCtD
Mivacurium—Arrhythmia—Pravastatin—atherosclerosis	0.012	0.0212	CcSEcCtD
Mivacurium—Erythema—Niacin—atherosclerosis	0.0119	0.021	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0115	0.0203	CcSEcCtD
Mivacurium—Muscle spasms—Niacin—atherosclerosis	0.0114	0.0202	CcSEcCtD
Mivacurium—Anaphylactic shock—Lovastatin—atherosclerosis	0.0113	0.0199	CcSEcCtD
Mivacurium—Muscle spasms—Pravastatin—atherosclerosis	0.0112	0.0199	CcSEcCtD
Mivacurium—Anaphylactic shock—Ezetimibe—atherosclerosis	0.0111	0.0196	CcSEcCtD
Mivacurium—Skin disorder—Ezetimibe—atherosclerosis	0.0107	0.019	CcSEcCtD
Mivacurium—Urticaria—Rosuvastatin—atherosclerosis	0.0106	0.0187	CcSEcCtD
Mivacurium—Anaphylactic shock—Simvastatin—atherosclerosis	0.0105	0.0186	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.01	0.0177	CcSEcCtD
Mivacurium—Anaphylactic shock—Niacin—atherosclerosis	0.00969	0.0171	CcSEcCtD
Mivacurium—Anaphylactic shock—Pravastatin—atherosclerosis	0.00954	0.0169	CcSEcCtD
Mivacurium—Tachycardia—Niacin—atherosclerosis	0.00945	0.0167	CcSEcCtD
Mivacurium—Skin disorder—Niacin—atherosclerosis	0.00941	0.0166	CcSEcCtD
Mivacurium—Hypotension—Niacin—atherosclerosis	0.00905	0.016	CcSEcCtD
Mivacurium—Urticaria—Lovastatin—atherosclerosis	0.00896	0.0158	CcSEcCtD
Mivacurium—Dizziness—Rosuvastatin—atherosclerosis	0.0088	0.0156	CcSEcCtD
Mivacurium—Urticaria—Ezetimibe—atherosclerosis	0.00879	0.0155	CcSEcCtD
Mivacurium—Rash—Rosuvastatin—atherosclerosis	0.00839	0.0148	CcSEcCtD
Mivacurium—Dermatitis—Rosuvastatin—atherosclerosis	0.00838	0.0148	CcSEcCtD
Mivacurium—Urticaria—Simvastatin—atherosclerosis	0.00838	0.0148	CcSEcCtD
Mivacurium—Urticaria—Niacin—atherosclerosis	0.0077	0.0136	CcSEcCtD
Mivacurium—Urticaria—Pravastatin—atherosclerosis	0.00758	0.0134	CcSEcCtD
Mivacurium—Dizziness—Lovastatin—atherosclerosis	0.00746	0.0132	CcSEcCtD
Mivacurium—Dizziness—Ezetimibe—atherosclerosis	0.00732	0.0129	CcSEcCtD
Mivacurium—Rash—Lovastatin—atherosclerosis	0.00711	0.0126	CcSEcCtD
Mivacurium—Dermatitis—Lovastatin—atherosclerosis	0.0071	0.0126	CcSEcCtD
Mivacurium—Dizziness—Simvastatin—atherosclerosis	0.00698	0.0123	CcSEcCtD
Mivacurium—Rash—Ezetimibe—atherosclerosis	0.00698	0.0123	CcSEcCtD
Mivacurium—Dermatitis—Ezetimibe—atherosclerosis	0.00697	0.0123	CcSEcCtD
Mivacurium—Rash—Simvastatin—atherosclerosis	0.00665	0.0118	CcSEcCtD
Mivacurium—Dermatitis—Simvastatin—atherosclerosis	0.00665	0.0117	CcSEcCtD
Mivacurium—Dizziness—Niacin—atherosclerosis	0.00641	0.0113	CcSEcCtD
Mivacurium—Dizziness—Pravastatin—atherosclerosis	0.00631	0.0111	CcSEcCtD
Mivacurium—Rash—Niacin—atherosclerosis	0.00611	0.0108	CcSEcCtD
Mivacurium—Dermatitis—Niacin—atherosclerosis	0.0061	0.0108	CcSEcCtD
Mivacurium—Rash—Pravastatin—atherosclerosis	0.00601	0.0106	CcSEcCtD
Mivacurium—Dermatitis—Pravastatin—atherosclerosis	0.00601	0.0106	CcSEcCtD
Mivacurium—CHRM3—Metabolism—ALOX15—atherosclerosis	0.000327	0.000753	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLA2G2A—atherosclerosis	0.000327	0.000753	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALOX5AP—atherosclerosis	0.000327	0.000753	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA2—atherosclerosis	0.000327	0.000753	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—F2—atherosclerosis	0.000327	0.000752	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—AGT—atherosclerosis	0.000327	0.000752	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—GHRL—atherosclerosis	0.000325	0.000749	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NAMPT—atherosclerosis	0.000324	0.000747	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCG5—atherosclerosis	0.000323	0.000744	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000323	0.000743	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LIPC—atherosclerosis	0.000322	0.000743	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOC3—atherosclerosis	0.00032	0.000738	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—LEP—atherosclerosis	0.00032	0.000737	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LDLR—atherosclerosis	0.000318	0.000733	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA4—atherosclerosis	0.000318	0.000732	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000317	0.000729	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA4—atherosclerosis	0.000315	0.000725	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPA—atherosclerosis	0.000312	0.000719	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CETP—atherosclerosis	0.000311	0.000716	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCR2—atherosclerosis	0.000306	0.000705	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EDNRA—atherosclerosis	0.000306	0.000705	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000305	0.000703	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCR2—atherosclerosis	0.000303	0.000698	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EDNRA—atherosclerosis	0.000303	0.000698	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000302	0.000696	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—BGN—atherosclerosis	0.000302	0.000696	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—F2—atherosclerosis	0.000302	0.000695	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA5—atherosclerosis	0.000299	0.000689	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—GHRL—atherosclerosis	0.000298	0.000687	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—SCARB1—atherosclerosis	0.000298	0.000686	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000296	0.000683	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—GHRL—atherosclerosis	0.000295	0.000681	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CCL2—atherosclerosis	0.000294	0.000677	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL4—atherosclerosis	0.000293	0.000674	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CCL2—atherosclerosis	0.000291	0.000671	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00029	0.000668	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL4—atherosclerosis	0.00029	0.000668	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—KNG1—atherosclerosis	0.000288	0.000664	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLA2G1B—atherosclerosis	0.000288	0.000663	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AGTR1—atherosclerosis	0.000287	0.00066	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	0.000286	0.000658	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000284	0.000654	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—HMGCR—atherosclerosis	0.000281	0.000648	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALOX5—atherosclerosis	0.000278	0.000641	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA2—atherosclerosis	0.000274	0.00063	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—INS—atherosclerosis	0.000273	0.00063	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA2—atherosclerosis	0.000271	0.000624	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CCL2—atherosclerosis	0.000269	0.000619	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGF1—atherosclerosis	0.000264	0.000609	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—KNG1—atherosclerosis	0.000262	0.000603	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—UTS2—atherosclerosis	0.000261	0.000601	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGTR1—atherosclerosis	0.00026	0.0006	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.000259	0.000597	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.000258	0.000595	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000258	0.000594	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—MMP2—atherosclerosis	0.000256	0.000589	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000254	0.000584	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ABCA1—atherosclerosis	0.000251	0.000577	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CX3CR1—atherosclerosis	0.00025	0.000576	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASR—atherosclerosis	0.00025	0.000576	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NAMPT—atherosclerosis	0.000249	0.000575	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LIPC—atherosclerosis	0.000248	0.000571	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.000248	0.000571	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.000248	0.000571	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOC3—atherosclerosis	0.000246	0.000567	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CX3CL1—atherosclerosis	0.000245	0.000565	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LDLR—atherosclerosis	0.000245	0.000564	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—EDN1—atherosclerosis	0.000243	0.00056	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.000243	0.00056	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	0.000241	0.000555	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000241	0.000554	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CETP—atherosclerosis	0.000239	0.000551	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.000239	0.00055	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CNR2—atherosclerosis	0.000233	0.000536	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	0.000232	0.000535	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	0.000232	0.000534	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000232	0.000533	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.00023	0.00053	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.00023	0.00053	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.00023	0.000529	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000229	0.000528	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000229	0.000528	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000227	0.000523	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000221	0.000508	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000219	0.000504	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000219	0.000503	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000217	0.000499	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000216	0.000498	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—HMOX1—atherosclerosis	0.000215	0.000495	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000213	0.00049	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000208	0.00048	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000207	0.000477	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000206	0.000475	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOB—atherosclerosis	0.000206	0.000475	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000206	0.000474	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000205	0.000473	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000205	0.000472	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000204	0.00047	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000203	0.000467	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000202	0.000465	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTM1—atherosclerosis	0.0002	0.000462	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.0002	0.000461	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.0002	0.00046	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000198	0.000456	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LPL—atherosclerosis	0.000197	0.000453	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000193	0.000444	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GPX1—atherosclerosis	0.000192	0.000442	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000192	0.000441	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.00019	0.000437	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CD36—atherosclerosis	0.000187	0.000431	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000186	0.000429	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000185	0.000425	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000183	0.000422	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000181	0.000418	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000181	0.000417	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000181	0.000417	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.00018	0.000415	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000179	0.000413	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000179	0.000413	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000178	0.000411	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000178	0.000411	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—atherosclerosis	0.000177	0.000408	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000177	0.000407	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000176	0.000406	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000176	0.000406	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000176	0.000406	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000175	0.000402	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000175	0.000402	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000175	0.000402	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARA—atherosclerosis	0.000174	0.0004	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000169	0.00039	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AGT—atherosclerosis	0.000168	0.000388	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000168	0.000386	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000165	0.000381	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—atherosclerosis	0.000165	0.00038	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CAV1—atherosclerosis	0.000163	0.000376	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOA1—atherosclerosis	0.000163	0.000375	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000162	0.000373	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.00016	0.000369	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOB—atherosclerosis	0.000158	0.000365	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000155	0.000356	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000154	0.000355	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000154	0.000354	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000153	0.000353	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000152	0.000351	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPL—atherosclerosis	0.000151	0.000348	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000151	0.000347	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.00015	0.000345	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000149	0.000344	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CG—atherosclerosis	0.000149	0.000343	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000148	0.000342	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GPX1—atherosclerosis	0.000148	0.00034	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD36—atherosclerosis	0.000144	0.000331	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—atherosclerosis	0.000144	0.000331	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000142	0.000327	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—INS—atherosclerosis	0.000141	0.000324	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000141	0.000324	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000137	0.000316	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000136	0.000314	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000136	0.000314	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000136	0.000313	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000135	0.000311	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARA—atherosclerosis	0.000134	0.000308	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000132	0.000305	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000131	0.000303	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000131	0.000302	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.00013	0.0003	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.00013	0.0003	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AGT—atherosclerosis	0.000129	0.000298	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000129	0.000298	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—atherosclerosis	0.000129	0.000297	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000129	0.000297	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000128	0.000295	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—atherosclerosis	0.000127	0.000292	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000126	0.000291	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAV1—atherosclerosis	0.000126	0.000289	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA1—atherosclerosis	0.000125	0.000289	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000125	0.000289	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—atherosclerosis	0.000124	0.000285	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.000123	0.000283	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000122	0.000281	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.00012	0.000276	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000119	0.000275	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000119	0.000273	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000118	0.000272	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.000114	0.000264	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—atherosclerosis	0.000113	0.00026	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	0.000111	0.000255	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—atherosclerosis	0.00011	0.000254	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	0.00011	0.000253	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—INS—atherosclerosis	0.000108	0.00025	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGT—atherosclerosis	0.000108	0.000249	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGT—atherosclerosis	0.000107	0.000247	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—atherosclerosis	0.000106	0.000244	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LEP—atherosclerosis	0.000106	0.000244	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CAV1—atherosclerosis	0.000105	0.000242	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LEP—atherosclerosis	0.000105	0.000242	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—atherosclerosis	0.000105	0.000242	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA1—atherosclerosis	0.000105	0.000241	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CAV1—atherosclerosis	0.000104	0.00024	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA1—atherosclerosis	0.000104	0.000239	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ESR1—atherosclerosis	0.000101	0.000233	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ESR1—atherosclerosis	0.0001	0.000231	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2—atherosclerosis	0.0001	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—atherosclerosis	9.93e-05	0.000229	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2—atherosclerosis	9.9e-05	0.000228	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	9.57e-05	0.00022	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—atherosclerosis	9.5e-05	0.000219	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	9.48e-05	0.000218	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	9.16e-05	0.000211	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	9.08e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—INS—atherosclerosis	9.06e-05	0.000209	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—INS—atherosclerosis	8.97e-05	0.000207	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL2—atherosclerosis	8.91e-05	0.000205	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL2—atherosclerosis	8.83e-05	0.000203	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—atherosclerosis	8.76e-05	0.000202	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—atherosclerosis	8.69e-05	0.0002	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—atherosclerosis	8.68e-05	0.0002	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	8.32e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	8.24e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—atherosclerosis	7.94e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—atherosclerosis	7.87e-05	0.000181	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	7.05e-05	0.000162	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	6.98e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	6.81e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	6.74e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—atherosclerosis	6.7e-05	0.000154	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—atherosclerosis	6.64e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—atherosclerosis	6.37e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—atherosclerosis	6.31e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	6.31e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	6.24e-05	0.000144	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	6.2e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	6.18e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	6.14e-05	0.000141	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	6.12e-05	0.000141	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	5.72e-05	0.000132	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—atherosclerosis	5.68e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	5.67e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT3—atherosclerosis	5.67e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT3—atherosclerosis	5.61e-05	0.000129	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	5.41e-05	0.000125	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	5.36e-05	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	5.25e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	5.2e-05	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—atherosclerosis	4.37e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.96e-05	9.12e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.92e-05	9.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—atherosclerosis	3.65e-05	8.41e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—atherosclerosis	3.62e-05	8.33e-05	CbGpPWpGaD
